Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Inotiv (NOTV) Research & Development (2016 - 2023)

Inotiv filings provide 14 years of Research & Development readings, the most recent being $2.3 million for Q1 2023.

  • On a quarterly basis, Research & Development rose 54.75% to $2.3 million in Q1 2023 year-over-year; TTM through Mar 2023 was $7.0 million, a 98.59% increase, with the full-year FY2022 number at $5.7 million, up 285.04% from a year prior.
  • Research & Development hit $2.3 million in Q1 2023 for Inotiv, up from $1.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $2.3 million in Q1 2023 to a low of $105000.0 in Q2 2020.
  • Median Research & Development over the past 5 years was $230000.0 (2019), compared with a mean of $710000.0.
  • Biggest five-year swings in Research & Development: fell 18.26% in 2020 and later surged 629.7% in 2022.
  • Inotiv's Research & Development stood at $162000.0 in 2019, then decreased by 1.23% to $160000.0 in 2020, then soared by 498.12% to $957000.0 in 2021, then soared by 57.26% to $1.5 million in 2022, then soared by 51.56% to $2.3 million in 2023.
  • The last three reported values for Research & Development were $2.3 million (Q1 2023), $1.5 million (Q4 2022), and $1.5 million (Q3 2022) per Business Quant data.